Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma

Chudgar and colleagues evaluated clinicopathologic variables and characteristics of treatment for 539 patients who had undergone pulmonary metastasectomy for soft-tissue sarcoma at the Memorial Sloan Kettering Cancer Center. They report several factors associated with improved survival, including minimally invasive approaches and histological subtype.

Commentaries from Berry and from Hoang consider the application of these findings to patient selection for metastasectomy:

Evidence for resection of sarcoma pulmonary metastases: More, but better? Mark F. Berry. 

Resection of pulmonary sarcomatous metastases: Cut to cure? Chuong D. Hoang.